Trials / Conditions / Prevention of Meningococcal Infection
Prevention of Meningococcal Infection
6 registered clinical trials studyying Prevention of Meningococcal Infection.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Persistence of Antibodies and Kinetics of B Cell Response in Healthy Children After Vaccination With MCC Vacci NCT00310713 | Novartis Vaccines | Phase 4 |
| Completed | Immunogenicity, Safety, Tolerability and Ability to Prime for Memory of Meningococcal C Conjugate Vaccine in H NCT00311415 | Novartis Vaccines | Phase 3 |
| Completed | Kinetics of B Cell Response in Infants Menjugate Vaccination NCT00310700 | Novartis | Phase 4 |
| Completed | Persistence of Antibody Response to N. Meningitidis Group C in Children NCT00316654 | Novartis Vaccines | Phase 4 |
| Completed | Persistence of Immune Response After Vaccination With MCC NCT00310687 | Novartis | Phase 4 |
| Completed | Immunogenicity, Safety and Tolerability, of Chiron Meningococcal C Conjugate Vaccine Administered to Healthy P NCT00310674 | Novartis | Phase 3 |